Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 2
2021 3
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Growth hormone receptor gene disruption.
List EO, Duran-Ortiz S, Kulkarni P, Davis E, Mora-Criollo P, Berryman DE, Kopchick JJ. List EO, et al. Among authors: kulkarni p. Vitam Horm. 2023;123:109-149. doi: 10.1016/bs.vh.2022.12.004. Epub 2023 Aug 24. Vitam Horm. 2023. PMID: 37717983
Mice with gene alterations in the GH and IGF family.
Qian Y, Berryman DE, Basu R, List EO, Okada S, Young JA, Jensen EA, Bell SRC, Kulkarni P, Duran-Ortiz S, Mora-Criollo P, Mathes SC, Brittain AL, Buchman M, Davis E, Funk KR, Bogart J, Ibarra D, Mendez-Gibson I, Slyby J, Terry J, Kopchick JJ. Qian Y, et al. Among authors: kulkarni p. Pituitary. 2022 Feb;25(1):1-51. doi: 10.1007/s11102-021-01191-y. Epub 2021 Nov 19. Pituitary. 2022. PMID: 34797529 Free PMC article. Review.
A novel peptide antagonist of the human growth hormone receptor.
Basu R, Nahar K, Kulkarni P, Kerekes O, Sattler M, Hall Z, Neggers S, Holub JM, Kopchick JJ. Basu R, et al. Among authors: kulkarni p. J Biol Chem. 2021 Jan-Jun;296:100588. doi: 10.1016/j.jbc.2021.100588. Epub 2021 Mar 24. J Biol Chem. 2021. PMID: 33774052 Free PMC article.
Growth hormone receptor antagonism downregulates ATP-binding cassette transporters contributing to improved drug efficacy against melanoma and hepatocarcinoma in vivo.
Basu R, Qian Y, Mathes S, Terry J, Arnett N, Riddell T, Stevens A, Funk K, Bell S, Bokal Z, Batten C, Smith C, Mendez-Gibson I, Duran-Ortiz S, Lach G, Mora-Criollo PA, Kulkarni P, Davis E, Teaford E, Berryman DE, List EO, Neggers S, Kopchick JJ. Basu R, et al. Among authors: kulkarni p. Front Oncol. 2022 Jul 5;12:936145. doi: 10.3389/fonc.2022.936145. eCollection 2022. Front Oncol. 2022. PMID: 35865483 Free PMC article.
Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo.
Qian Y, Basu R, Mathes SC, Arnett NA, Duran-Ortiz S, Funk KR, Brittain AL, Kulkarni P, Terry JC, Davis E, Singerman JT, Henry BE, List EO, Berryman DE, Kopchick JJ. Qian Y, et al. Among authors: kulkarni p. Cancers (Basel). 2020 Dec 4;12(12):3640. doi: 10.3390/cancers12123640. Cancers (Basel). 2020. PMID: 33291663 Free PMC article.
Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma.
Basu R, Kulkarni P, Qian Y, Walsh C, Arora P, Davis E, Duran-Ortiz S, Funk K, Ibarra D, Kruse C, Mathes S, McHugh T, Brittain A, Berryman DE, List EO, Okada S, Kopchick JJ. Basu R, et al. Among authors: kulkarni p. Cancers (Basel). 2019 Sep 12;11(9):1352. doi: 10.3390/cancers11091352. Cancers (Basel). 2019. PMID: 31547367 Free PMC article.